MEDICAL AND NEURO-ONCOLOGY
Gopi Kesaria Prithviraj(University of South Florida), J. R. Silber(Duke Medical Center), R. Chen(University of South Florida), S. Yacoub(Novartis (United States)), John DeGroot(University of California, San Francisco), K. Hunter(The University of Texas MD Anderson Cancer Center), S. Khatua(Novartis (United States)), Jaqueline Willemann Rogerio(Mechanical Solutions (United States)), Evans Le(The University of Texas MD Anderson Cancer Center), A. B. Porter(Novartis (United States)), W. A. Yung, Tribhawan S. Vats(University of South Florida), Jonathan R. Olson(Duke Medical Center), Matthew J. McGirt(Unknown), J. Drappatz(Brigham and Women's Hospital), John M. Slopis(The University of Texas MD Anderson Cancer Center), Michael Pearlman(Sarah Cannon), Stacey L. Parker(The University of Queensland), N. J. Karlin(Moffitt Cancer Center), Robin Jump(University of Pittsburgh), Nicholas C. DeVito(Duke Medical Center), Amaury Desjardin(Duke University), Margie Gerena-Lewis(University of Akron), Monica Loghin(The University of Texas MD Anderson Cancer Center), Timothy F. Cloughesy(University of California, Los Angeles), Claudius Conrad(Boston University), Eddie Pan(Moffitt Cancer Center), Lola B. Chambless(Vanderbilt University), Balázs Halmos(Montefiore Medical Center), Z. S. Sadighi(NewYork–Presbyterian Hospital), A. C. Dueck(Novartis (United States)), Mingwei Yu(Moffitt Cancer Center), Eun-Yeup Lee(The University of Texas MD Anderson Cancer Center), S. R. Sommers(University of South Florida), K. R. Hess, Sandra Ictech(Duke Medical Center), Morris D. Groves(Texas Oncology), Jianjiao Ni(Shanghai Medical College of Fudan University), Laila Hassam-Malani(The University of Texas MD Anderson Cancer Center), R. C. Thompson(The University of Texas MD Anderson Cancer Center)
Cited by 2
Related Papers
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.7k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k